Funded Biotechnology Startups in Germany
Among the 50 most recent German biotechnology rounds shown, the largest disclosed amount is $358M for Tubulis (Series C) on 2025-10-19.
Among the 50 most recent German biotechnology rounds shown, the largest disclosed amount is $358M for Tubulis (Series C) on 2025-10-19. That figure dwarfs the next-largest disclosed amounts visible here (e.g., $158M for Impulse Dynamics on 2025-12-10 and $150M for atai Life Sciences on 2025-10-16), while several others cluster well below $100M (for instance, $68M for SciRhom on 2024-07-09; $59M for Exciva on 2026-01-20). A second observation is the stage/label mix: 24 of 50 entries carry either “undisclosed” or “Series Unknown” (e.g., smartbax on 2026-06-30 is undisclosed, while Heidelberg Pharma on 2026-03-07 is “Series Unknown”). Geographically, Munich repeatedly appears across different round dates (e.g., smartbax 2026-06-30; Amplifold 2025-12-10; Tubulis 2025-10-19; immatics biotechnologies 2024-10-10), suggesting a concentration in and around Bavaria. Temporally, rounds span from 2024-07-03 (Viride, undisclosed) to the latest date in the list, 2026-06-30 (smartbax, undisclosed).
Most recent rounds
50 of 10151 more funded startups
This page shows the 50 most recent rounds (back to Jul 2024). The full 101-company history for this listing is available on a paid plan.
Unlock all 101 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What’s the largest disclosed round in this German biotech slice, and how far above the rest is it?
Tubulis’ $358M (Series C) on 2025-10-19 is the clear outlier; the next-largest disclosed amounts visible are $158M (Impulse Dynamics, 2025-12-10) and $150M (atai Life Sciences, 2025-10-16). Most other disclosed rounds sit below $100M, such as $68M for SciRhom on 2024-07-09 and $59M for Exciva on 2026-01-20.
Are there notable city clusters, or is the geography evenly spread?
Munich (including nearby “München/Bayern” entries) shows up repeatedly across years: smartbax (2026-06-30, undisclosed), Amplifold (2025-12-10, $6M), Tubulis (2025-10-19, $358M), and immatics biotechnologies (2024-10-10, $150M). Other cities appear, but none show the same recurring frequency in the visible rows.
Which entries fall in the most recent 90 days of the listing window?
Using the latest date shown (2026-06-30), the most recent 90 days cover mid-March to late June 2026, including smartbax (2026-06-30, undisclosed), HMNC Brain Health (2026-06-15, $50M), Pacifico Biolabs (2026-05-27, $8M), NVision Imaging Technologies (2026-05-13, $38M), and Primogene (2026-04-29, $5M).
What stage label mix dominates: named rounds, “Series Unknown,” or “undisclosed” amounts?
A large share of rows are not fully quantified by either stage or amount: 24 of 50 entries are either “undisclosed” or labeled “Series Unknown.” Examples include “undisclosed” amounts like smartbax (2026-06-30) and Tacalyx (2026-04-29), alongside “Series Unknown” entries like Heidelberg Pharma (2026-03-07, $20M) and Formo (2025-01-14, $36M).
Is there a low-end outlier in disclosed amounts compared to the rest?
Lucid Genomics’ $1M pre-seed round on 2024-09-02 is the smallest disclosed amount in the rows shown. By comparison, other low disclosed entries cluster higher, such as Picea Biosolutions at $310K (2026-04-01) and Zendia at $930K (2024-12-10), with many disclosed rounds in the multi-million range (e.g., NanoStruct $3M on 2026-05-11).
Are there any clear temporal edges or a denser period inside the window?
The window edges run from 2024-07-03 (Viride, undisclosed) to 2026-06-30 (smartbax, undisclosed). Within that span, several rounds cluster into the first half of 2026 (e.g., multiple entries from April 2026 such as Primogene 2026-04-29, Tacalyx 2026-04-29, and mbiomics 2026-04-28), suggesting periods of repeated financing announcements rather than a uniform spread.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.